Research from J. Fortun et al broadens understanding of liver transplant.

According to recent research from Madrid, Spain, "Aspergillus galactomannan (GM) antigenemia is an early marker of invasive aspergillosis (IA), but may yield false-positive results. A prospective study, testing GM periodically in serum samples of liver transplant recipients, was performed."

"An index more than or equal to 0.5 were considered positive. Positive GM in samples from patients without any other criteria of proven or probable IA was considered as false-positive. The test was performed weekly during the first month after transplantation. Three patients developed IA. In total, 414 serum samples from 85 liver transplant recipients were analyzed. Mean number of …